REFERENCES
- Calabrese E. J. Human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit. Rev. Toxicol 2005, [CSA]
- Stedman's Medical Dictionary 27th ed. Lippincott Williams & Wilkins, New York 2000; 831
- Calabrese E. J. Hormesis: From marginalization to mainstream: A case for hormesis as the default dose-response model in risk assessment. Toxicol. Appl. Pharmacol 2004; 197: 125, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Calabrese E. J., Baldwin L. A. Chemotherapeutics and hormesis. Crit. Rev. Toxicol 2003; 33: 305, [PUBMED], [INFOTRIEVE], [CSA]
- Calabrese E. J., Blaine R. The occurrence of hormetic dose response in the toxicological literature. The hormesis database: An overview. Toxicol. Appl. Pharmacol 2005; 202: 289, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Basly J.-P., Marre-Fournier F., Le Bail J.-C., Habrioux G., Chulia A. J. Estrogenic/anti-estrogenic and scavenging properties of (E)-and (Z)-resveratrol. Life Sci 2000; 66: 769, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Goldberg D. M., Yan J., Soleas G. J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem 2003; 36: 79, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Meng X., Maliakal P., Lu H., Lee M.-J., Yang C. S. Urinary and plasma levels of reservatrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem 2004; 52: 935, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tsutsumi K., Kitagawa N., Niwa M., Yamaga S., Khalid H., Taniyama K., Himeno A., Shibata S. Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas. Cell. Mol. Neurobiol 1993; 13: 665, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reyno L. M., Egorin M. J., Eisenberger M. A., Sinibaldi V. J., Zuhowski E. G., Sridhara R. Development and validation of a pharmacokinetically based fixed dosing scheme for suramin. J. Clin. Oncol 1995; 13: 2187, [PUBMED], [INFOTRIEVE], [CSA]
- Garcia-Shurmann J. M., Schulze H., Haupt G., Pastor J., Allolio B., Senge T. Suramin treatment in hormone- and chemotherapy-refractory prostate cancer. Urology 1999; 53: 535, [CROSSREF], [CSA]
- Reddel R. R., Sutherland R. L. Tamoxifen stimulation of human breast cancer cell proliferation in vitro: A possible model for tamoxifen tumour flare. Eur. J. Cancer Clin. Oncol 1984; 20: 1419, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Vos D., Slee P. H.T.J., Briggs R. J., Stevenson D. Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels. Cancer Chemother. Pharmacol 1998; 42: 512, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Perez E. A., Gandara D. R., Edelman M. J., O'Donnell R., Lauder I. J., DeGregorio M. Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies. Cancer Invest 2003; 21: 1, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Coosen R., De Jong P W.J., Schwarz F. Influence of estradiol on the total uptake and incorporation of thymidine in human breast cancer (MCF-7) in long-term cell culture. Mol. Cell Biochem 1982; 42: 155, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lippman J., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976; 36: 4595, [PUBMED], [INFOTRIEVE], [CSA]
- Wang C., Kurzer M. S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer 1997; 28: 236, [PUBMED], [INFOTRIEVE], [CSA]
- Tamir S., Eizenberg M., Somjen D., Stern N., Shelach R., Kaye A., Vaya J. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 2000; 60: 5704, [PUBMED], [INFOTRIEVE], [CSA]
- Berthois Y., Bourrie B., Galiegue S., Vidal H., Carayon P., Martin P. M., Casellas P. SR31747A is a sigma receptor ligand exhibiting antitumoral activity both in vitro and in vivo. Br. J. Cancer 2003; 88: 438, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kobayashi H., Terao T. The role of cell membrane-associated urinary trypsin inhibitor in tumor cell invasion and metastasis. Oncol. Rep 1997; 4: 65, [CSA]
- Dudich E., Semenkova L., Gorbatova E., Dudich I., Khromykh L., Tatulov E., Grechko G., Sukhikh G. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 1998; 19: 30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kang C.-D., Do I.-R., Kim K.-W., Ahn B.-K., Kim S.-H., Chung B.-S., Jhun B.-H., Yoo M. A. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells. Exp. Mol. Med. 1999; 31: 76, [PUBMED], [INFOTRIEVE], [CSA]